PATENT CLAIM ANALYSIS

Application Number: 15741875
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "063000"]

Abstract:
The present invention provides a compound having a TrkA inhibitory activity or a pharmaceutically acceptable salt thereof. The present invention relates to a compound represented by Formula (I): wherein -L- is —C(═X)—, or the like, —Z— is —NR 5 —, or the like, —Z A — is —NR 5A —, or the like, B is substituted or unsubstituted aromatic carbocyclyl, or the like, Y is a single bond, or the like, the ring C is a substituted or unsubstituted aromatic heterocycle, or the like, R 2  is a hydrogen atom, or the like, and the group represented by is a group represented by Formula: or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same.

Claim (Index 20):
The compound according to  claim 2 , wherein the group represented by Formula: is represented by Formula: wherein R 1 , R 3  and R 4  are the same as  claim 1 , or a pharmaceutically acceptable salt.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 86.0
- Lexical Diversity: 2.32787
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15501749', '16075409', '14387387', '16061155', '15120763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.82750028961899
- 35 USC 102 Novelty (BERT): 0.6114558391143569
- Combined Prediction Score: 0.8058958445685267
- Mean Citation Score: 529.0451559999998
- Max Citation Score: 630.57385
- Similarity Product: 450.12128737991753

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test